Pulse Oximetry in the diagnosis of critical congenital cardiac disease

1. Introduction

Pulse oximetry screening is a non-invasive, bedside test used in asymptomatic newborns to detect subclinical hypoxemia, which may indicate duct-dependent "critical" congenital heart disease (CCHD). It aims to identify lesions before the ductus arteriosus closes and cardiovascular collapse occurs.

2. Screening Targets

3. Methodology

4. Updated Screening Algorithm (AAP 2025)

A pass requires SpO2β‰₯95% in both extremities with ≀3% difference.

  1. PASS: * SpO2β‰₯95% in BOTH right hand and foot.

    • AND ≀3% difference between sites.
  2. IMMEDIATE FAIL:

    • SpO2<90% in EITHER right hand or foot.
  3. INDETERMINATE (Repeat after 1 hour):

    • SpO2 is 90βˆ’94% in either site OR >3% difference between sites.
    • Action: Repeat screen once (Note: 2025 update reduces retests to one).
    • If the repeat screen does not meet "Pass" criteria, it is a FAIL.

5. Evaluation of Failed Screen

Infants failing the screen require urgent medical evaluation:

6. Limitations